Wall Street Associates’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-7,064
Closed -$446K 345
2015
Q3
$446K Hold
7,064
0.09% 227
2015
Q2
$516K Sell
7,064
-2,404
-25% -$174K 0.05% 267
2015
Q1
$619K Hold
9,468
0.06% 256
2014
Q4
$616K Buy
9,468
+3,707
+64% +$239K 0.06% 241
2014
Q3
$346K Sell
5,761
-1,380
-19% -$90.2K 0.04% 291
2014
Q2
$495K Sell
7,141
-1,580
-18% -$102K 0.04% 261
2014
Q1
$570K Hold
8,721
0.05% 256
2013
Q4
$540K Buy
+8,721
New +$505K 0.04% 259

Other funds holding STJ

Wall Street Associates's STJ Position: Q4 2015 in Review

Wall Street Associates sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 7,064 shares — an estimated $446K sold.

Wall Street Associates first reported a position in STJ in Q4 2013 and held it in 8 quarters. The position peaked at $619K in Q1 2015. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Wall Street Associates reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Wall Street Associates sold 7,064 St Jude Medical shares in Q4 2015, an estimated $446K.
  • Wall Street Associates first reported a position in St Jude Medical in Q4 2013 and held it in 8 quarters.
  • Wall Street Associates's St Jude Medical position peaked at $619K in Q1 2015.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Wall Street Associates's 13F filing for Q4 2015, filed 11 Feb 2016.